Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Total Assets (Quarterly): 47.58M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 47.58M |
| June 30, 2023 | 63.20M |
| March 31, 2023 | 80.81M |
| December 31, 2022 | 73.73M |
| September 30, 2022 | 83.50M |
| June 30, 2022 | 108.95M |
| March 31, 2022 | 132.45M |
| December 31, 2021 | 155.45M |
| September 30, 2021 | 174.67M |
| June 30, 2021 | 196.18M |
| March 31, 2021 | 261.32M |
| Date | Value |
|---|---|
| December 31, 2020 | 171.59M |
| September 30, 2020 | 183.32M |
| June 30, 2020 | 197.12M |
| March 31, 2020 | 162.50M |
| December 31, 2019 | 176.60M |
| September 30, 2019 | 142.39M |
| June 30, 2019 | 157.02M |
| March 31, 2019 | 166.93M |
| December 31, 2018 | 102.58M |
| September 30, 2018 | 32.31M |
| December 31, 2017 | 31.87M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
47.58M
Minimum
Sep 2023
261.32M
Maximum
Mar 2021
141.81M
Average
158.97M
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 117.53B |
| Axonics Inc | 774.17M |
| Johnson & Johnson | 178.29B |
| Boston Scientific Corp | 38.08B |
| Ambrx Biopharma Inc (DELISTED) | 271.50M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 43.04M |
| Shareholders Equity (Quarterly) | 4.541M |
| Current Ratio | 1.894 |